Home › Funds › BAKER BROS. ADVISORS LP › MIRM
BAKER BROS. ADVISORS LP position in MIRM
MIRUM PHARMACEUTICALS INC · Health Care
BAKER BROS. ADVISORS LP reported holding 445,975 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$52.2M, representing 0.27% of its reported portfolio and ranking #36 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed MIRM holdings in 8 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BAKER BROS. ADVISORS LP's MIRM position evolved
BAKER BROS. ADVISORS LP first disclosed a stake in MIRM in Q3 2023 at 190,476 shares (US$6.0M). The position peaked in Q2 2026 at 445,975 shares, worth US$52.2M. Across 8 filings, BAKER BROS. ADVISORS LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 445,975 shares valued at US$52.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 190.48K | $6.02M | New |
| Q4 2023 | 190.48K | $5.62M | Hold |
| Q1 2024 | 190.48K | $4.78M | Hold |
| Q2 2024 | 190.48K | $6.51M | Hold |
| Q3 2024 | 190.48K | $7.43M | Hold |
| Q4 2024 | 190.48K | $7.88M | Hold |
| Q1 2026 | 445.98K | $41.20M | New |
| Q2 2026 | 445.98K | $52.21M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MIRM and 13F data
MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 61 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MIRM
- Frazier Life Sciences Management, L.P. 7.68M sh · $899.06M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.25M sh · $146.20M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.24M sh · $144.70M · Q2 2026
- Novo Holdings A/S 1.12M sh · $131.70M · Q2 2026
- TCG Crossover Management, LLC 1.06M sh · $124.33M · Q2 2026
- BVF INC/IL 1.06M sh · $123.63M · Q2 2026
- Rock Springs Capital Management LP 798.14K sh · $93.44M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 24.65M sh · $91.66M · Q2 2026
- CAPSTONE INVESTMENT ADVISORS, LLC 18.45M sh · $68.30M · Q2 2026
- EMERALD ADVISERS, LLC 468.30K sh · $54.82M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 420.21K sh · $49.19M · Q2 2026
- BOONE CAPITAL MANAGEMENT LLC 415.64K sh · $48.66M · Q2 2026
More on BAKER BROS. ADVISORS LP
FAQ
How long has BAKER BROS. ADVISORS LP held MIRM?
BAKER BROS. ADVISORS LP has disclosed MIRM holdings in 8 of the last 12 reported quarters, going back to Q3 2023.
What is BAKER BROS. ADVISORS LP's current position in MIRM?
As of Q2 2026, BAKER BROS. ADVISORS LP holds 445.98K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $52.21M, representing 0.27% of its reported portfolio and ranking #36.
Has BAKER BROS. ADVISORS LP been buying or selling MIRM?
In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP held unchanged its position in MIRM. The position peaked in Q2 2026 at 445.98K shares.
Which other funds hold MIRM?
Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.